STEFANIE SICRE: Open Payments
NPI 1205613890 · FT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 58 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,291
Food & beverage: $1,291
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $250 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $160 |
| LivaNova USA, Inc. | 2 | $143 |
| Indivior Inc. | 1 | $95 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| Corium, LLC | 4 | $82 |
| Tris Pharma Inc | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $53 |
Products named: VRAYLAR, CAPLYTA, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, REXULTI, SPRAVATO, Azstarys, Dyanavel XR, FANAPT.
Industry payments across FL — which companies pay providers there.
